Mark Sheptoff Financial Planning LLC Cuts Holdings in Veeva Systems Inc. (NYSE:VEEV)

Mark Sheptoff Financial Planning LLC lessened its stake in Veeva Systems Inc. (NYSE:VEEV) by 2.3% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 27,532 shares of the technology company’s stock after selling 650 shares during the period. Veeva Systems accounts for 2.8% of Mark Sheptoff Financial Planning LLC’s portfolio, making the stock its 8th biggest holding. Mark Sheptoff Financial Planning LLC’s holdings in Veeva Systems were worth $5,039,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. Advisors Asset Management Inc. bought a new stake in shares of Veeva Systems in the 1st quarter worth $28,000. DSM Capital Partners LLC bought a new stake in Veeva Systems in the fourth quarter worth about $29,000. Vermillion & White Wealth Management Group LLC acquired a new stake in Veeva Systems in the 4th quarter valued at about $32,000. Blue Trust Inc. boosted its position in shares of Veeva Systems by 3,460.0% during the 2nd quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock valued at $33,000 after purchasing an additional 173 shares in the last quarter. Finally, First Financial Corp IN acquired a new position in shares of Veeva Systems in the 1st quarter worth approximately $35,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on VEEV shares. Morgan Stanley cut their target price on shares of Veeva Systems from $210.00 to $173.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. Truist Financial raised their price objective on Veeva Systems from $197.00 to $207.00 and gave the stock a “hold” rating in a research note on Tuesday, September 3rd. Evercore ISI decreased their target price on Veeva Systems from $230.00 to $200.00 and set an “in-line” rating on the stock in a report on Friday, May 31st. Stifel Nicolaus reduced their target price on Veeva Systems from $250.00 to $210.00 and set a “buy” rating for the company in a report on Friday, May 31st. Finally, Canaccord Genuity Group dropped their price target on Veeva Systems from $220.00 to $210.00 and set a “hold” rating on the stock in a research note on Friday, May 31st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Veeva Systems has an average rating of “Moderate Buy” and a consensus target price of $229.96.

Veeva Systems Trading Up 0.4 %

NYSE VEEV opened at $215.61 on Thursday. Veeva Systems Inc. has a 1-year low of $162.72 and a 1-year high of $236.90. The firm’s fifty day simple moving average is $198.15 and its 200-day simple moving average is $201.71. The company has a market capitalization of $34.91 billion, a PE ratio of 63.60, a price-to-earnings-growth ratio of 2.12 and a beta of 0.81.

Insider Buying and Selling at Veeva Systems

In other news, SVP Jonathan Faddis sold 2,353 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $200.00, for a total transaction of $470,600.00. Following the completion of the sale, the senior vice president now directly owns 9,035 shares of the company’s stock, valued at approximately $1,807,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.50% of the company’s stock.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.